Specialist discusses suboptimal results of anti-VEGF therapy, switching treatment in non-responders

BASSANO DEL GRAPPA, Italy — Variable results, inferior to what could be expected from anti-VEGF therapy for age-related macular degeneration, are observed in the real world of clinical practice, according to one specialist.In addition, criteria for classifying non-responders and switching them to another anti-VEGF drug should be clarified.